Patent Assignment
Reel/Frame 064057/0069
Corrective Assignment to Correct the the Correct Assignee Name as Owl Rock Opportunistic Master Fund I, L.P... Previously Recorded at Reel: 063903 Frame: 0707. Assignor(S) Hereby Confirms the Security Interest.
Recorded: 2023-06-22
Pages: 120
Assignor
ADC THERAPEUTICS SA
Executed: 2022-08-15
Assignee
OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
399 PARK AVENUE, 38TH FL, NEW YORK, NEW YORK, 10022
Covered Properties
(3)
Dosage Regime
Application:
17/938,193 →
Publication:
US 2023/0106885
Anti-Psma Conjugates
Application:
18/056,080 →
Publication:
US 2023/0201366
Anti-Il-13RALPHA2 Conjugates
Application:
18/056,082 →
Publication:
US 2023/0285580
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 6, 2022
From: UNGAR, DAVID RODNEY; FEINGOLD, JAY MARSHALL
To: ADC THERAPEUTICS AMERICA, INC.
Reel/Frame 061333/0485 →
Assignment of Assignor's Interest
Oct 6, 2022
From: ADC THERAPEUTICS AMERICA, INC.
To: ADC THERAPEUTICS SA
Reel/Frame 061333/0501 →
Assignment of Assignor's Interest
Oct 6, 2022
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 061333/0537 →
Patent Security Agreement
Dec 28, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 063738/0001 →
Security Interest
Jun 7, 2023
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTNISTIC MASTER FUND I, L.P.
Reel/Frame 063903/0707 →
Patent Security Agreement
Aug 25, 2023
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 064718/0868 →